ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue32,753,00028,216,00025,638,00022,859,000
Cost of Revenue7,718,0006,688,0005,793,0004,239,000
Gross Profit25,035,00021,528,00019,845,00018,620,000
Operating Expenses
Research Development5,259,0005,007,0004,385,0004,101,000
Selling General and Administrative7,365,0005,878,0005,837,0005,663,000
Non Recurring----
Others500,000500,000500,000500,000
Total Operating Expenses20,842,00017,573,00016,015,00014,003,000
Operating Income or Loss11,911,00010,643,0009,623,0008,856,000
Income from Continuing Operations
Total Other Income/Expenses Net-6,714,000-2,916,000-1,739,000-2,211,000
Earnings Before Interest and Taxes11,911,00010,643,0009,623,0008,856,000
Interest Expense-1,348,000-1,150,000-1,047,000-719,000
Income Before Tax5,197,0007,727,0007,884,0006,645,000
Income Tax Expense-490,0002,418,0001,931,0001,501,000
Minority Interest----
Net Income From Continuing Ops5,687,0005,309,0005,953,0005,144,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income5,687,0005,309,0005,953,0005,144,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares5,657,0005,283,0005,923,0005,118,000